Search Results - "Meerpohl, H.G."
-
1
Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer: results of a phase I trial
Published in European journal of cancer (1990) (01-05-2004)“…This prospective, parallel-group, dose-escalation study evaluated the cardiac safety of trastuzumab (Herceptin®) plus epirubicin/cyclophosphamide (EC) in women…”
Get full text
Journal Article -
2
Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer
Published in European journal of cancer (1990) (01-05-2004)Get full text
Journal Article -
3
Extended phase II study of paclitaxel as a 3-h infusion in patients with ovarian cancer previously treated with platinum
Published in European journal of cancer (1990) (01-03-1997)“…An extended phase II study was performed to evaluate single-agent paclitaxel as salvage chemotherapy for ovarian cancer. The aim of this study was to evaluate…”
Get full text
Journal Article -
4
Randomized Study Comparing Carboplatin/Cyclophosphamide and Cisplatin/Cyclophosphamide as First-Line Treatment in Patients with Stage III/IV Epithelial Ovarian Cancer and Small Volume Disease
Published in Gynecologic oncology (01-07-1997)“…Several randomized studies in patients with advanced ovarian cancer have dealt with the comparison of cisplatin and carboplatin when given as either a single…”
Get full text
Journal Article -
5
Course, patterns, and risk-factors for chemotherapy-induced emesis in cisplatin-pretreated patients: a study with ondansetron
Published in European journal of cancer (1990) (1992)“…Vomiting and nausea are the most distressing side-effects of cancer chemotherapy. With standard antiemetic regimens (e.g. metoclopramide based combinations)…”
Get more information
Journal Article -
6
Prospective investigation of the significance of cardiac markers, NT-pro Brain Natriuretic Peptide (NT-proBNP) and Troponin T (TnT), in the Hercules study of epirubicin/cyclophosphamide with or without trastuzumab (Herceptin®)
Published in European journal of cancer supplements (01-03-2004)Get full text
Journal Article -
7
Clinical phase I study with one-hour paclitaxel infusion
Published in Annals of oncology (01-05-1998)“…Background Paclitaxel (PAC) is one of the major anti-cancer drugs, effective in different tumors. Studies with 24-hour infusion with 135 mg/m2 and a three-hour…”
Get full text
Journal Article -
8
Clinical and pharmacokinetic phase I study with taxol® given as short 1-hour intravenous infusion
Published in European journal of cancer (1990) (01-09-1997)Get full text
Journal Article -
9
Positron emission tomography helps to diagnose tumor emboli and residual disease in choriocarcinoma
Published in Annals of oncology (01-04-1996)“…Positron emission tomography (PET) has been shown capable of identifying malignant tissues. WB-PET imaging in two women with metastatic choriocarcinoma is…”
Get full text
Journal Article -
10
Pathophysiology, severity, pattern, and risk factors for carboplatin-induced emesis
Published in Oncology (01-01-1996)“…Carboplatin has proven efficacy in the treatment of ovarian cancer and has been proven to be less toxic compared to the parent compound cisplatin…”
Get more information
Journal Article -
11
Paclitaxel-Induced “Recall” Soft Tissue Ulcerations Occurring at the Site of Previous Subcutaneous Administration of Paclitaxel in Low Doses
Published in Gynecologic oncology (01-01-1996)“…The presented case reports a rare complication of paclitaxel misuse: recall soft tissue injury at the site of previous subcutaneous paclitaxel administration…”
Get full text
Journal Article Conference Proceeding -
12
Role of prostaglandins on the regulation of macrophage proliferation and cytotoxic functions
Published in Prostaglandins (01-05-1986)“…The data presented show different effects of prostaglandins on proliferation and cytotoxic effector functions of murine bone-marrow derived mononuclear cells…”
Get more information
Journal Article -
13
Formation of prostaglandins by ovarian carcinomas
Published in Prostaglandins (01-05-1985)“…Tissue contents of prostaglandins (PG) PGE2, PGE2a and 6-keto-PGF1a (degradation product of PGI2) were determined in specimens of advanced human ovarian cancer…”
Get more information
Journal Article -
14
Chemotherapy for stage III-IV ovarian cancer: the CAP-regimen in previously untreated patients
Published in Onkologie (01-01-1982)“…Twenty-nine patients with advanced previously untreated epithelial ovarian cancer (FIGO stage III + IV) received induction chemotherapy with CAP…”
Get more information
Journal Article